Anavex Life Sciences Corp. (AVXL) vs Voyager Therapeutics, Inc. (VYGR)

A side-by-side comparison of Anavex Life Sciences Corp. and Voyager Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVXL vs VYGR

growth of $100 · dividends reinvested · last 10y
AVXL -56.2% (-7.9%/yr)VYGR -79.6% (-14.7%/yr)AVXL compounded faster over this window
0200400600Start $10020182020202220242026$44$20
AVXL VYGR

AVXL vs VYGR: by the numbers

  • •VYGR is the larger company ($149M vs $148M market cap).
  • •Both run net losses; AVXL's is the smaller (0.00% vs -312.63% net margin).

Metrics side by side

Valuation

MetricAVXLVYGR
P/S ratioN/A4.31
P/B ratio1.320.96

Profitability

MetricAVXLVYGR
Gross margin0.00%-227.62%
Operating margin0.00%-326.56%
Net margin0.00%-312.63%
ROE-21.38%-69.78%
ROIC-27.25%-64.72%

Growth (annualized)

MetricAVXLVYGR
Revenue CAGR (5Y)N/A-23.59%
Total return CAGR (5Y)-37.74%-0.08%

Frequently asked

How have AVXL and VYGR total returns compared?
Over the past 10 years, AVXL delivered -7.93% and VYGR delivered -14.87% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.